GRDN: financial statements from SEC — TradeAlmanac

GRDN

Guardian Pharmacy Services, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	337m	377m	344m	329m	314m	300m
Cost of revenue	260m	303m	276m	265m	254m	239m
Gross profit	76m	75m	68m	64m	61m	61m
Selling, general and administrative	59m	58m	56m	51m	165m	44m
Operating income	18m	16m	13m	13m	−105m	17m
Pre-tax income	18m	17m	13m	13m	−106m	16m
Income tax	5m	7m	4m	4m	176,000	0
Net income	13m	10m	9m	9m	−122m	16m
Earnings per share	0.21	0.16	0.15	0.15	−2.00	—
Earnings per share, diluted	0.21	0.15	0.14	0.15	−2.00	—
Weighted average shares	36,855	23m	22m	10m	8m	—
Weighted average shares, diluted	37,071	24m	23m	10m	8m	—

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	65m	66m	36m	19m	14m	5m	37m	2m
Receivables	112m	102m	106m

Cash flow

Metric	Mar 31, 2026	Jun 30, 2025	Mar 31, 2025
Operating cash flow	6m	—	18m
Depreciation and amortisation	6m	—	5m
Share-based compensation	2m	4m	4m
Investing cash flow	−5m	—	−6m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)